NorthWest Biotherapeutics Inc (NWBO)

[underpar71]

There has been accumulation/covering post PR. The fact that a submission will happen, and in the short term, makes this riskier (or stupid) to short. The coordination now will be between MM's holding it while allowing their shorts to cover. Any positive catalyst that brings in volume buying should make this pop significantly. Post submission, this should be valued in the 8-10B range prior to approval, IMO. so, $7-8 is reasonable to me.